The new therapeutic treatments that greatly improve the lives of patients with thalassemia (Mediterranean anemia) and sickle cell disease will be presented during the annual Panhellenic Scientific event, which is organizing in Kavala The Hellenic Thalassemia Association (ESA).
All the latest scientific data, recent global medical studies and the latest developments related to thalassemia and sickle cell disease will be discussed and analyzed In the context of the three -day scientific event, organized by the ESA. in cooperation with units Thalassemia and Hellenic Cell Disease of Hippocratic General Hospital of Thessaloniki, Hippocrates General Hospital of Athens (Center for Hemoglobin Paths and Complications) and Kavala General Hospital.
“More than 400 people from Greece and Cyprus are expected to come to Kavala this three -day three days in order to watch the work, with the aim of informing and training the sufferers, on issues related to the treatment of diseases,” the ESA President said. Basil Municipality.
“This year, for the first time,” says Mr. Dimos, “the city was chosen of Kavala To host this great scientific event, which is being held as part of the celebration of World Thalassemia Day, With nationwide informational events and distribution of material to promote voluntary blood donation in central squares of municipalities across the country. “
It is worth noting that the annual scientific event of the ESA. It is carried out with the scientific support of doctors who systematically monitor sufferers, so it is the only source of medical news for thalassemia over time.
“Today, patients with thalassemia (Mediterranean anemia) and sickle cell disease are closely monitored by a total of 36 special units available in various nursing institutions in the country. You realize, therefore, that this large community of patients, parents, doctors and nurses working in these units are participating in this annual event in order to have a comprehensive scientific information, ”notes the President of the ESA.
Improving the quality of life of patients with thalassemia
More than 2,200 people are, today, patients with thalassemia. Of these, 600 patients are found in areas of northern Greece, while 1,000 people are patients with sickle cell disease and all are monitored by the same medical units.
“It is a fact that thanks to the evolution of science,” Mr Dimos notes, “the life expectancy of these patients now touches the average life of the general population. However, there are always new, important scientific data, Medicines, which now shrink the intervals between transfers required For patients with Mediterranean anemia. Also important are developments in the issue of gene treatment of the disease. All of this, as you can see, further improve patients’ quality of life and are expected to be presented and discussed extensively. “
During the three -day scientific event, the Hellenic Thalassemia Association will be honored to be honored to two health executives at the Kavala General Hospital.
As Mr. Dimos points out, “This is the Kavaliotis doctor and former Deputy Minister of Health Michalis Timosides, whose contribution and immediate intervention were decisive to resolve, in difficult times, in difficult times. Period of Memorandums and the economic crisis, the fair and timeless problems of the sufferers from thalassemia and sickle cell disease. We will also be honored to be awarded to the nurse Ourania Tsakirakis, who has now retired, for his exemplary, tireless service, excellent nursing care and the human support he has offered all these years to the sufferers of the Mediterranean Unit.